Originally published bySydney Morning Herald
NeuroScientific Biopharmaceuticals has reported an 80% response rate from five Crohn’s disease patients treated with its StemSmart cell therapy, with all patients showing improvement.
🇦🇺
More news from AustraliaAustralia
OCEANIA
Related News
Accused 'money mules' refused bail after allegedly moving millions from scams
14h ago
9 missing after Washington paper mill tank implosion and officials say there's no hope of survivors
5h ago
The Government said it needed to restrict climate change litigation to protect business confidence. Officials disagreed
19h ago
A decade after the last census disaster, the security of this year’s count is at risk
13h ago
Bulk carrier rescues two fishermen and Smokey the dog after boat sinks
13h ago